1. Nolvadex Adjuvant Trial Organisation: Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by the Nolvadex Adjuvant Trial Organisation. Lancet i: 836–840, 1985
2. Baum M: Adjuvant ‘Nolvadex’ therapy: six-year analysis of the NATO-trial. Rev Endocrine-Related Cancer, (Suppl) 17: 5–16, 1985
3. Anon: Review of mortality results in randomised trials in early breast cancer. Lancet ii: 1205–1206, 1984
4. Peto R: Over-view of adjuvant trials in breast cancer. Paper read before the Consensus Development Conference on Adjuvant Chemotherapy for Breast Cancer, National Institutes of Health, Washington DC, USA, Sep 1985
5. Ludwig Breast Cancer Study Group: Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis. Lancet i: 1256–1260, 1984